0

524663

BIBCL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BHARAT IMMUNOLOGICALS & BIOLOG Share Price Today

Investment Returns

Over 1 Month -1.94% Over 3 Months 0.52% Over 6 Months -9.02% Over 1 Year -29.36%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BHARAT IMMUNOLOGICALS & BIOLOG fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 74.30
  • P/E Ratio (TTM) -4.10
  • Beta 0.78
  • Book Value / share -7.53
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -4.92
info icon alternate text

BHARAT IMMUNOLOGICALS & BIOLOG Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.81
Net Profit -4.92
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.14
EBITDA -4.53
Effective Tax Rate (%) 26.01
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.06
Net Profit -4.59
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.06
EBITDA -4.22
Effective Tax Rate (%) 23.11
Particulars MAR 2023 (Values in Cr)
Revenue 7.65
Operating Expense 13.82
Net Profit -3.88
Net Profit Margin (%) -50.71
Earnings Per Share (EPS) -0.90
EBITDA -3.53
Effective Tax Rate (%) 31.69
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 6.43
Net Profit -4.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.08
EBITDA -4.62
Effective Tax Rate (%) 26.06
Particulars SEP 2022 (Values in Cr)
Revenue 26.48
Operating Expense 30.75
Net Profit -3.08
Net Profit Margin (%) -11.63
Earnings Per Share (EPS) -0.71
EBITDA -2.17
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 44.61
Operating Expense 67.94
Net Profit -16.64
Net Profit Margin (%) -37.30
Earnings Per Share (EPS) -3.85
EBITDA -15.02
Effective Tax Rate (%) 25.28
Particulars MAR 2022 (Values in Cr)
Revenue 78.39
Operating Expense 89.18
Net Profit -8.75
Net Profit Margin (%) -11.16
Earnings Per Share (EPS) -2.03
EBITDA -3.88
Effective Tax Rate (%) 9.59
Particulars MAR 2021 (Values in Cr)
Revenue 85.33
Operating Expense 111.22
Net Profit -18.11
Net Profit Margin (%) -21.22
Earnings Per Share (EPS) 1.10
EBITDA -19.19
Effective Tax Rate (%) 25.19
Particulars MAR 2020 (Values in Cr)
Revenue 66.84
Operating Expense 82.22
Net Profit -10.21
Net Profit Margin (%) -15.27
Earnings Per Share (EPS) -2.36
EBITDA -9.21
Effective Tax Rate (%) 28.09
Particulars MAR 2019 (Values in Cr)
Revenue 83.65
Operating Expense 95.24
Net Profit -5.79
Net Profit Margin (%) -6.92
Earnings Per Share (EPS) -1.57
EBITDA -5.09
Effective Tax Rate (%) 21.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -35.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.48
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -4.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.33
EBITDA Margin -22.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.74
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin -13.79
Particulars MAR 2019 (Values in Cr)
Book Value / Share 7.10
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.47
EBITDA Margin -6.10
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.73
Total Assets 185.66
Total Liabilities 185.66
Total Equity 87.79
Share Outstanding 4
Price to Book Ratio -4.09
Return on Assets (%) -9.18
Return on Capital (%) -10.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.00
Total Assets 212.72
Total Liabilities 212.72
Total Equity 105.35
Share Outstanding 4
Price to Book Ratio -18.99
Return on Assets (%) -4.11
Return on Capital (%) -4.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.53
Total Assets 103.98
Total Liabilities 103.98
Total Equity 34.04
Share Outstanding 4
Price to Book Ratio 82.73
Return on Assets (%) -17.41
Return on Capital (%) -29.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 126.82
Total Liabilities 126.82
Total Equity 20.47
Share Outstanding 4
Price to Book Ratio 1.23
Return on Assets (%) -8.05
Return on Capital (%) -43.43
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7.93
Total Assets 124.96
Total Liabilities 124.96
Total Equity 30.67
Share Outstanding 4
Price to Book Ratio 1.08
Return on Assets (%) -4.63
Return on Capital (%) -9.21
Particulars MAR 2023 (Values in Cr)
Net Income -22.85
Cash from Operations 10.88
Cash from Investing 0.46
Cash from Financing -14.70
Net change in Cash -3.35
Free Cash Flow 10.88
Particulars MAR 2022 (Values in Cr)
Net Income -9.68
Cash from Operations -42.11
Cash from Investing 0.53
Cash from Financing 45.00
Net change in Cash 3.41
Free Cash Flow -42.11
Particulars MAR 2021 (Values in Cr)
Net Income -24.20
Cash from Operations 11.77
Cash from Investing 0.66
Cash from Financing -12.20
Net change in Cash 0.24
Free Cash Flow 11.77
Particulars MAR 2020 (Values in Cr)
Net Income -14.20
Cash from Operations 34.07
Cash from Investing 0.91
Cash from Financing -34.41
Net change in Cash 0.57
Free Cash Flow 34.07
Particulars MAR 2019 (Values in Cr)
Net Income -7.37
Cash from Operations -32.09
Cash from Investing 0.69
Cash from Financing 30.70
Net change in Cash -0.69
Free Cash Flow -32.07
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.03 13.24 1.55 245.46 23.12 38.85
BLISS GVS PHARMA LTD. 481.70 39.10 4.28 5108.73 118.35 486.15
CIPLA LTD 1355.80 28.77 3.18 109527.67 1165.55 1672.20
FERMENTA BIOTECH LTD. 318.45 14.05 2.30 937.23 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2266.85 39.91 16.93 38401.81 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.03 22.40 4.12 245.46 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 544.75 24.42 4.25 1574.91 490.00 789.95
ASTRAZENECA PHARMA IND LT 8514.50 111.20 24.38 21286.25 7630.00 10033.55
BLISS GVS PHARMA LTD. 481.70 51.96 4.42 5108.73 118.35 486.15

BHARAT IMMUNOLOGICALS & BIOLOG shareholding pattern

Holding
40.74%
59.25%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BHARAT IMMUNOLOGICALS & BIOLOG Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
17.20 0.40 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 17.10
  • 26 Days 17.30
  • 10 Days 17.20
  • 50 Days 17.40
  • 12 Days 17.20
  • 100 Days 17.80
  • 20 Days 17.30
  • 200 Days 19.10
17.22 PIVOT
First Support 16.97 First Resistance 17.39 Second Support 16.80 Second Resistance 17.64 Third Support 16.55 Third Resistance 17.81
RSI 46.45 ADX 41.66 MACD -0.11 Williams % R -63.57 Commodity Channel Index (CCI) -69.07
Date 2026-06-18 Week 13000.00 Same Day 6818.00 Month 11165.00
1 Year 0.78 3 Year 0.81
Over 1 Month
-1.94% down
Over 1 Year
-29.36% down
Over 3 Months
0.52% down
Over 3 Years
-10.04% down
Over 6 Months
-9.02% down
Over 5 Years
-27.49% down

BHARAT IMMUNOLOGICALS & BIOLOG Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bharat Immunological & Biological Corporation Ltd?

Answer Field

Bharat Immunological & Biological Corporation Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 17.20 as on Jun 19 2026 01:46 PM.

What is the Market Cap of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

The market cap of Bharat Immunological & Biological Corporation Ltd for NSE ₹ 0.00 & for BSE ₹ 74.30 as on Jun 19 2026 01:46 PM.

What is the 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 25.00 and ₹ 14.10.

What is 1 year return for Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 1 year returns on the stock has been -29.36%.

What is the P/E Ratio of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

As on Jun 19 2026 01:46 PM the price-to-earnings (PE) ratio for Bharat Immunological & Biological Corporation Ltd share is -4.10.

What is the PB ratio of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

As on Jun 19 2026 01:46 PM, the price-to-book (PB) ratio for Bharat Immunological & Biological Corporation Ltd share is -7.53.

How to Buy Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

You can trade in Bharat Immunological & Biological Corporation Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bharat Immunological & Biological Corporation Ltd Share on Bajaj Broking App?

Answer Field

To buy Bharat Immunological & Biological Corporation Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bharat Immunological & Biological Corporation Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|